IMPAX Announces FDA Approval of Generic Wellbutrin XL 300 mg (Business Wire via Yahoo! Finance)
HAYWARD, Calif.----IMPAX Laboratories, Inc. announced today that the U.S. Food and Drug Administration has granted final approval of the Company's Abbreviated New Drug Application for a generic version of Wellbutrin XL, 300 mg.

FilterWire EZ(TM) Embolic Protection System Cleared By FDA For Carotid Artery Stenting (Medical News Today)
Boston Scientific Corporation (NYSE: BSX) today announced it has received clearance from the U.S. Food and Drug Administration (FDA) to market its FilterWire EZ(TM) Embolic Protection System for use in carotid artery stenting (CAS) procedures. [click link for full article]

BioSante Pharmaceuticals Receives FDA Approval of Bio-E-Gel(R) (estradiol gel), to be Marketed as Elestrin(TM) (FinanzNachrichten)
BioSante Pharmaceuticals, ( Nachrichten ) Inc. (Amex:BPA) today announced that it received U.S. Food and Drug Administration (FDA) approval for the marketing of Bio-E-Gel (estradiol gel) in the United States.